Scoring system for risk stratification of viral reactivation during prophylactic antiviral treatment in Korean patients with hepatitis B undergoing anticancer chemotherapy: A multicenter study-Reference-Cited by-同舟云学术

Scoring system for risk stratification of viral reactivation during prophylactic antiviral treatment in Korean patients with hepatitis B undergoing anticancer chemotherapy: A multicenter study

Published:2018-07-10 Issue:10 Volume:90 Page:1593-1603
ISSN:0146-6615
Container-title:Journal of Medical Virology
language:en
Short-container-title:J Med Virol

Author:

Kim Hwi Young¹,Yoo Jeong-Ju²^ORCID,Oh Sohee³,Yu Su Jong⁴,Kim Yoon Jun⁴,Yoon Jung-Hwan⁴,Kim Won⁵,Jung Yong Jin⁵,Kim Bo Hyun⁶,Kim Chang-Min⁶,Park Joong-Won⁶,Lee Jeong-Hoon⁴^ORCID

Affiliation:

1. Department of Internal Medicine; College of Medicine, Ewha Womans University; Seoul Republic of Korea

2. Division of Gastroenterology and Hepatology, Department of Internal Medicine; Soonchunhyang University Bucheon Hospital; Bucheon Republic of Korea

3. Department of Biostatistics; Seoul Metropolitan Government Seoul National University Boramae Medical Center; Seoul Republic of Korea

4. Department of Internal Medicine, Seoul National University Hospital; Seoul National University College of Medicine; Seoul Republic of Korea

5. Department of Internal Medicine; Seoul Metropolitan Government Seoul National University Boramae Medical Center; Seoul Republic of Korea

6. Center for Liver Cancer, Research Institute and Hospital; National Cancer Center; Goyang Republic of Korea

Publisher

Wiley

Subject

Infectious Diseases,Virology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/jmv.25241/fullpdf

Reference33 articles.

1. Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity;Ott;Vaccine,2012

2. Systematic review: the effect of preventive lamivudine on hepatitis B reactivation during chemotherapy;Loomba;Ann Intern Med,2008

3. Management of patients with hepatitis B who require immunosuppressive therapy;Hwang;Nat Rev Gastroenterol Hepatol,2014

4. Reactivation of hepatitis B virus and hepatitis C virus in patients with cancer;Torres;Nat Rev Clin Oncol,2012

5. Hepatitis B virus reactivation after cytotoxic chemotherapy: the disease and its prevention;Mindikoglu;Clin Gastroenterol Hepatol,2006

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatitis B Virus Reactivation in Cancer Patients Receiving Chemotherapy—A Systematic Review and Meta-Analysis;Seminars in Oncology;2024-08

2. Tenofovir versus Entecavir on Outcomes of Hepatitis B Virus-Related Hepatocellular Carcinoma After FOLFOX-Hepatic Arterial Infusion Chemotherapy;Journal of Hepatocellular Carcinoma;2023-11

3. KASL clinical practice guidelines for management of chronic hepatitis B;Clinical and Molecular Hepatology;2022-04-01

4. Prophylaxis, diagnosis and therapy of infections in patients undergoing high-dose chemotherapy and autologous haematopoietic stem cell transplantation. 2020 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO);Annals of Hematology;2020-10-20

5. Hepatitis B reactivation in patients with hepatitis B core antibody positive and surface antigen negative on immunosuppressants;World Journal of Meta-Analysis;2019-05-31